These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12629536

  • 1. Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports.
    Khan A, Khan SR, Walens G, Kolts R, Giller EL.
    Neuropsychopharmacology; 2003 Mar; 28(3):552-7. PubMed ID: 12629536
    [Abstract] [Full Text] [Related]

  • 2. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [Abstract] [Full Text] [Related]

  • 3. Placebo response and antidepressant clinical trial outcome.
    Khan A, Detke M, Khan SR, Mallinckrodt C.
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [Abstract] [Full Text] [Related]

  • 4. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A, Schwartz K, Kolts RL, Ridgway D, Lineberry C.
    Biol Psychiatry; 2007 Jul 01; 62(1):65-71. PubMed ID: 17141744
    [Abstract] [Full Text] [Related]

  • 5. Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.
    Khan A, Kolts RL, Thase ME, Krishnan KR, Brown W.
    Am J Psychiatry; 2004 Nov 01; 161(11):2045-9. PubMed ID: 15514405
    [Abstract] [Full Text] [Related]

  • 6. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N, Papakostas GI.
    J Clin Psychiatry; 2012 Oct 01; 73(10):1300-6. PubMed ID: 23140647
    [Abstract] [Full Text] [Related]

  • 7. Study designs and outcomes in antidepressant clinical trials.
    Khan A, Schwartz K.
    Essent Psychopharmacol; 2005 Oct 01; 6(4):221-6. PubMed ID: 16041918
    [Abstract] [Full Text] [Related]

  • 8. Simple options for improving signal detection in antidepressant clinical trials.
    Mallinckrodt CH, Meyers AL, Prakash A, Faries DE, Detke MJ.
    Psychopharmacol Bull; 2007 Oct 01; 40(2):101-14. PubMed ID: 17514189
    [Abstract] [Full Text] [Related]

  • 9. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N, Papakostas GI.
    J Clin Psychiatry; 2012 May 01; 73(5):676-83. PubMed ID: 22569112
    [Abstract] [Full Text] [Related]

  • 10. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI, Fava M.
    Eur Neuropsychopharmacol; 2009 Jan 01; 19(1):34-40. PubMed ID: 18823760
    [Abstract] [Full Text] [Related]

  • 11. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 01; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 12. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M, Schaffer A, Smart KA, Levitt AJ, Lanctôt KL, Grysman NH.
    J Clin Psychiatry; 2012 Feb 01; 73(2):e277-87. PubMed ID: 22401489
    [Abstract] [Full Text] [Related]

  • 13. Magnitude of placebo response and response variance in antidepressant clinical trials using structured, taped and appraised rater interviews compared to traditional rating interviews.
    Khan A, Faucett J, Brown WA.
    J Psychiatr Res; 2014 Apr 01; 51():88-92. PubMed ID: 24477068
    [Abstract] [Full Text] [Related]

  • 14. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI.
    J Clin Psychiatry; 2010 Jun 01; 71(6):682-8. PubMed ID: 20573327
    [Abstract] [Full Text] [Related]

  • 15. Obtained effect size as a function of sample size in approved antidepressants: a real-world illustration in support of better trial design.
    Gibertini M, Nations KR, Whitaker JA.
    Int Clin Psychopharmacol; 2012 Mar 01; 27(2):100-6. PubMed ID: 22233698
    [Abstract] [Full Text] [Related]

  • 16. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1365-71. PubMed ID: 19906341
    [Abstract] [Full Text] [Related]

  • 17. Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.
    Weisler R, McIntyre RS, Bauer M.
    Expert Rev Neurother; 2013 Nov 01; 13(11):1183-200. PubMed ID: 24175721
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?
    Ioannidis JP.
    Philos Ethics Humanit Med; 2008 May 27; 3():14. PubMed ID: 18505564
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant dose reduction and the risk of relapse in major depressive disorder.
    Papakostas GI, Perlis RH, Seifert C, Fava M.
    Psychother Psychosom; 2007 May 27; 76(5):266-70. PubMed ID: 17700046
    [Abstract] [Full Text] [Related]

  • 20. Duration of initial antidepressant treatment and subsequent relapse of major depression.
    Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K.
    J Clin Psychopharmacol; 2015 Feb 27; 35(1):75-6. PubMed ID: 25502491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.